CoChat

Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma

Open access

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Abstract

Despite no apparent defects in T cell priming and recruitment to tumors, a large subset of T cell rich tumors fail to respond to immune checkpoint blockade (ICB). We leveraged a neoadjuvant anti-PD-1 trial in patients with hepatocellular carcinoma (HCC), as well as additional samples collected from patients treated off-label, to explore correlates of response to ICB within T cell-rich tumors. We show that ICB response correlated with the clonal expansion of intratumoral CXCL13+CH25H+IL-21+PD-1+CD4+ T helper cells ("CXCL13+ T H") and Granzyme K+ PD-1+ effector-like CD8+ T cells, whereas terminally exhausted CD39 hi TOX hi PD-1 hi CD8+ T cells dominated in nonresponders. CD4+ and CD8+ T cell clones that expanded post-treatment were found in pretreatment biopsies. Notably, PD-1+TCF-1+ (Progenitor-exhausted) CD8+ T cells shared clones mainly with effector-like cells in responders or terminally exhausted cells in nonresponders, suggesting that local CD8+ T cell differentiation occurs upon ICB. We found that these Progenitor CD8+ T cells interact with CXCL13+ T H within cellular triads around dendritic cells enriched in maturation and regulatory molecules, or "mregDC". These results suggest that discrete intratumoral niches that include mregDC and CXCL13+ T H control the differentiation of tumor-specific Progenitor exhasuted CD8+ T cells following ICB.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-023-02345-0

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 81 references

Cited by

See all 429

Metadata

Authors
Magen, A., Hamon, P., Fiaschi, N., Soong, B. Y., Park, M. D., Mattiuz, R., Humblin, E., Troncoso, L., D’souza, D., Dawson, T., Kim, J., Hamel, S., Buckup, M., Chang, C., Tabachnikova, A., Schwartz, H., Malissen, N., Lavin, Y., Soares-Schanoski, A., Giotti, B., Hegde, S., Ioannou, G., Gonzalez-Kozlova, E., Hennequin, C., Le Berichel, J., Zhao, Z., Ward, S. C., Fiel, I., Kou, B., Dobosz, M., Li, L., Adler, C., Ni, M., Wei, Y., Wang, W., Atwal, G. S., Kundu, K., Cygan, K. J., Tsankov, A. M., Rahman, A., Price, C., Fernandez, N., He, J., Gupta, N. T., Kim-Schulze, S., Gnjatic, S., Kenigsberg, E., Deering, R. P., Schwartz, M., Marron, T. U., Thurston, G., Kamphorst, A. O., & Merad, M.
Affiliations
  • Tisch Cancer Institute (US)
  • Regeneron (United States) (US)
  • Icahn School of Medicine at Mount Sinai (US)
Corresponding author
  • Schwartz, Myron
  • Marron, Thomas U.
  • Thurston, Gavin
  • Kamphorst, Alice O.
Venue
Nature Medicine
Published
2023-06
Volume
29
Issue
6
Pages
1389-1399
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W4380786205
Cited by
429
References
75
Citations by year
2026: 126 · 2025: 148 · 2024: 124 · 2023: 31
FWCI
52.02
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion, cc-by)
Funders
  • Bristol-Myers Squibb
  • Pfizer
  • Celgene
  • Regeneron Pharmaceuticals
  • National Institutes of Health (1r33ca263705-01, CA196521)
  • Genentech
  • EMD Serono
  • National Cancer Institute (R33CA263705, K00CA223043, R01CA154947, R01CA257195, U24CA224319, P30CA196521, R01CA254104)
  • National Institute of Allergy and Infectious Diseases (R01AI153363)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U01DK124165)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R33HD105593)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
hepatocellular carcinoma, anti-PD-1 therapy, immune checkpoint blockade, dendritic cells, CD4+ T helper cells, CD8+ T cell differentiation, T cell exhaustion, granzyme K, T cell clonal expansion, tumor microenvironment, neoadjuvant immunotherapy
MeSH terms
Cell Differentiation, Dendritic Cells, T-Lymphocytes, Helper-Inducer, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, CD8-Positive T-Lymphocytes, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma. https://app.cochat.ai/papers/10.1038/s41591-023-02345-0
The paper
Magen, A., Hamon, P., Fiaschi, N., Soong, B. Y., Park, M. D., Mattiuz, R., Humblin, E., Troncoso, L., D’souza, D., Dawson, T., Kim, J., Hamel, S., Buckup, M., Chang, C., Tabachnikova, A., Schwartz, H., Malissen, N., Lavin, Y., Soares-Schanoski, A., . . . Merad, M. (2023). Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma. Nature Medicine. https://doi.org/10.1038/s41591-023-02345-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.